Presentation is loading. Please wait.

Presentation is loading. Please wait.

Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival  J. Hunter Mehaffey, MD, Lily E. Johnston, MD,

Similar presentations


Presentation on theme: "Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival  J. Hunter Mehaffey, MD, Lily E. Johnston, MD,"— Presentation transcript:

1 Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival  J. Hunter Mehaffey, MD, Lily E. Johnston, MD, MPH, Robert B. Hawkins, MD, Eric J. Charles, MD, Leora Yarboro, MD, John A. Kern, MD, Gorav Ailawadi, MD, Irving L. Kron, MD, Ravi K. Ghanta, MD  The Annals of Thoracic Surgery  Volume 104, Issue 1, Pages (July 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Hemodynamic response (mean arterial pressure, cardiac index, and systemic vascular resistance) after methylene blue administration. Graphs are means and 95% confidence intervals. The Annals of Thoracic Surgery  , 36-41DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Vasopressor requirements (epinephrine and norepinephrine) after methylene blue administration. Graphs are means and 95% confidence intervals. The Annals of Thoracic Surgery  , 36-41DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival  J. Hunter Mehaffey, MD, Lily E. Johnston, MD,"

Similar presentations


Ads by Google